Nexus Investment Corporation (South Korea)

Net loss is posted as investment assets have been revalued and non-performing loans are written off though investment cooperative earnings increased. Nexus holds equity shares in HS BioFarm and Cesil to diversify investment into bio engineering and new parts industries. These companies have been lately listed on the stock exchange. Bonds have been issued to make up for fund shortage as capital decreased owing to net loss. IPO market will become poor in view of stock market unrest. It is more likely for investment recovery to be delayed further as expected earnings ratio declines in invested businesses. Sound capital structure is maintained. Risk of non-performing assets will be limited as write-off loss will be stable as bad checks were written off in large scales. Managed asset amount will grow gradually as more aggressive fund operation is likely with increased surplus funds while the company has been fully relieved from financial restructuring.